Synopsis
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] Drugs in Development
Lead Product(s) : Hyaluronic Acid,HYDROXYPROPYLMETHYLCELLULOSE
Therapeutic Area : Dermatology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Allergan Aesthetics looks to further develop the Hybrid Injectables category by introducing its first dual-effect product, which combines the two active ingredients - hyaluronic acid, a well-known ingredient found in facial fillers and calcium hydroxyapa...
Product Name : Juvederm Volux XC
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 29, 2022
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
APIs
Reply
09 Jan 2021
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
EXCIPIENTS
Reply
04 Nov 2024
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
ABOUT THIS PAGE
50
PharmaCompass offers a list of HYDROXYPROPYLMETHYLCELLULOSE API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right HYDROXYPROPYLMETHYLCELLULOSE manufacturer or HYDROXYPROPYLMETHYLCELLULOSE supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred HYDROXYPROPYLMETHYLCELLULOSE manufacturer or HYDROXYPROPYLMETHYLCELLULOSE supplier.
PharmaCompass also assists you with knowing the HYDROXYPROPYLMETHYLCELLULOSE API Price utilized in the formulation of products. HYDROXYPROPYLMETHYLCELLULOSE API Price is not always fixed or binding as the HYDROXYPROPYLMETHYLCELLULOSE Price is obtained through a variety of data sources. The HYDROXYPROPYLMETHYLCELLULOSE Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A HYDROXYPROPYLMETHYLCELLULOSE manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of HYDROXYPROPYLMETHYLCELLULOSE, including repackagers and relabelers. The FDA regulates HYDROXYPROPYLMETHYLCELLULOSE manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. HYDROXYPROPYLMETHYLCELLULOSE API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A HYDROXYPROPYLMETHYLCELLULOSE supplier is an individual or a company that provides HYDROXYPROPYLMETHYLCELLULOSE active pharmaceutical ingredient (API) or HYDROXYPROPYLMETHYLCELLULOSE finished formulations upon request. The HYDROXYPROPYLMETHYLCELLULOSE suppliers may include HYDROXYPROPYLMETHYLCELLULOSE API manufacturers, exporters, distributors and traders.
click here to find a list of HYDROXYPROPYLMETHYLCELLULOSE suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A HYDROXYPROPYLMETHYLCELLULOSE DMF (Drug Master File) is a document detailing the whole manufacturing process of HYDROXYPROPYLMETHYLCELLULOSE active pharmaceutical ingredient (API) in detail. Different forms of HYDROXYPROPYLMETHYLCELLULOSE DMFs exist exist since differing nations have different regulations, such as HYDROXYPROPYLMETHYLCELLULOSE USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A HYDROXYPROPYLMETHYLCELLULOSE DMF submitted to regulatory agencies in the US is known as a USDMF. HYDROXYPROPYLMETHYLCELLULOSE USDMF includes data on HYDROXYPROPYLMETHYLCELLULOSE's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The HYDROXYPROPYLMETHYLCELLULOSE USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of HYDROXYPROPYLMETHYLCELLULOSE suppliers with USDMF on PharmaCompass.
A HYDROXYPROPYLMETHYLCELLULOSE CEP of the European Pharmacopoeia monograph is often referred to as a HYDROXYPROPYLMETHYLCELLULOSE Certificate of Suitability (COS). The purpose of a HYDROXYPROPYLMETHYLCELLULOSE CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of HYDROXYPROPYLMETHYLCELLULOSE EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of HYDROXYPROPYLMETHYLCELLULOSE to their clients by showing that a HYDROXYPROPYLMETHYLCELLULOSE CEP has been issued for it. The manufacturer submits a HYDROXYPROPYLMETHYLCELLULOSE CEP (COS) as part of the market authorization procedure, and it takes on the role of a HYDROXYPROPYLMETHYLCELLULOSE CEP holder for the record. Additionally, the data presented in the HYDROXYPROPYLMETHYLCELLULOSE CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the HYDROXYPROPYLMETHYLCELLULOSE DMF.
A HYDROXYPROPYLMETHYLCELLULOSE CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. HYDROXYPROPYLMETHYLCELLULOSE CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of HYDROXYPROPYLMETHYLCELLULOSE suppliers with CEP (COS) on PharmaCompass.
HYDROXYPROPYLMETHYLCELLULOSE Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of HYDROXYPROPYLMETHYLCELLULOSE GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right HYDROXYPROPYLMETHYLCELLULOSE GMP manufacturer or HYDROXYPROPYLMETHYLCELLULOSE GMP API supplier for your needs.
A HYDROXYPROPYLMETHYLCELLULOSE CoA (Certificate of Analysis) is a formal document that attests to HYDROXYPROPYLMETHYLCELLULOSE's compliance with HYDROXYPROPYLMETHYLCELLULOSE specifications and serves as a tool for batch-level quality control.
HYDROXYPROPYLMETHYLCELLULOSE CoA mostly includes findings from lab analyses of a specific batch. For each HYDROXYPROPYLMETHYLCELLULOSE CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
HYDROXYPROPYLMETHYLCELLULOSE may be tested according to a variety of international standards, such as European Pharmacopoeia (HYDROXYPROPYLMETHYLCELLULOSE EP), HYDROXYPROPYLMETHYLCELLULOSE JP (Japanese Pharmacopeia) and the US Pharmacopoeia (HYDROXYPROPYLMETHYLCELLULOSE USP).
Comment (6)
